Adaptive Biotechnologies ... (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

7.37

0.01 (0.14%)

At close: May 01, 2025, 3:59 PM

8.40

13.98%

Pre-market: May 02, 2025, 08:50 AM EDT

Adaptive Biotechnologies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	47.92M	65.06M	90.03M	139.06M	123.44M	96.58M	55.03M	85.31M
Short-Term Investments	174.37M	281.34M	408.17M	214M	564.83M	480.29M	109.99M	106.84M
Long-Term Investments	33.66M	n/a	2.4M	217.15M	118.53M	105.44M	247K	8.9M
Other Long-Term Assets	5.18M	6.52M	4.46M	3.01M	2.74M	2.92M	247K	86K
Receivables	41.73M	37.97M	40.06M	17.41M	10.05M	12.68M	4.81M	5.58M
Inventory	8.44M	14.45M	14.45M	19.26M	14.06M	9.07M	7.84M	4.79M
Other Current Assets	11.29M	11.37M	9.44M	1.4M	2.5M	14.08M	n/a	n/a
Total Current Assets	283.75M	410.19M	562.15M	402.75M	726.91M	612.69M	180.72M	205.25M
Property-Plant & Equipment	94.38M	120.32M	164.21M	172.94M	139.04M	60.35M	19.13M	13.95M
Goodwill & Intangibles	122.4M	124.1M	125.8M	127.5M	129.2M	130.9M	132.6M	134.3M
Total Long-Term Assets	255.62M	250.95M	294.47M	520.6M	389.5M	299.61M	151.97M	157.24M
Total Assets	539.38M	661.13M	856.62M	923.34M	1.12B	912.3M	332.69M	362.49M
Account Payables	7.26M	7.72M	8.08M	3.31M	3.24M	4.45M	1.79M	1.96M
Deferred Revenue	55.69M	48.63M	64.11M	80.46M	73.32M	60.99M	12.7M	14.05M
Short-Term Debt	n/a	5.09M	9.23M	5.05M	3.53M	n/a	n/a	n/a
Other Current Liabilities	35.1M	13.69M	6.71M	10.59M	10.19M	4.74M	3.67M	1.93M
Total Current Liabilities	98.05M	88.02M	109.79M	113.81M	105.2M	78.31M	22.8M	21M
Long-Term Debt	n/a	130.66M	n/a	n/a	n/a	n/a	561.19M	n/a
Other Long-Term Liabilities	238.84M	n/a	125.36M	n/a	n/a	7.01M	6.1M	566.1M
Total Long-Term Liabilities	238.84M	264.84M	282.73M	205.44M	267.95M	262.95M	568M	566.1M
Total Liabilities	336.89M	352.86M	392.52M	319.24M	373.15M	341.26M	590.8M	587.11M
Total Debt	89.39M	229.43M	108M	111.74M	107.86M	36.61M	561.19M	561.67M
Common Stock	14K	14K	14K	14K	14K	12K	1K	1K
Retained Earnings	-1.3B	-1.14B	-919.08M	-718.89M	-511.61M	-365.48M	-295.91M	-249.42M
Comprehensive Income	n/a	215K	-4.12M	-1.14M	893K	671K	-107K	-166K
Shareholders Equity	202.71M	308.4M	464.17M	603.99M	743.27M	571.04M	-258.11M	-224.62M
Total Investments	208.03M	281.34M	408.17M	431.14M	683.36M	585.73M	109.99M	115.75M